How to strengthen the Medicaid Drug Rebate Program to address rising Medicaid prescription drug costs
- Collection:
- Health Policy and Services Research
- Series Title(s):
- Future of children's health care coverage
- Author(s):
- Park, Edwin, author
- Contributor(s):
- Georgetown University. Health Policy Institute. Center for Children and Families, issuing body.
- Publication:
- Washington, DC : Georgetown University Health Policy Institute, Center for Children and Families, January 2019
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Drug Costs Medicaid -- economics United States
- Genre(s):
- Technical Report
- Abstract:
- Key Findings. (1) The Medicaid Drug Rebate Program is highly effective. In 2016, rebates paid by drug manufacturers lowered Medicaid prescription drug costs by more than 51.3 percent, compared to rebate savings of only 19.9 percent in Medicare Part D. To help state Medicaid programs better address rising prescription drug costs, policymakers should consider proposals that build on and strengthen the rebate program, rather than weaken it. (2) Federal policymakers could consider options to strengthen the Medicaid Drug Rebate Program such as increasing the rebates to deter excessive launch prices and annual price increases, eliminating the cap on rebate amounts, and extending the rebate program to separate state CHIP programs. (3) State policymakers could adopt policies already available under federal law such as expanding and maximizing the supplemental rebates that states negotiate with drug manufacturers, increasing drug pricing transparency, and enhancing the use of drug effectiveness reviews.
- Copyright:
- Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. (More information)
- Extent:
- 1 online resource (1 PDF file (13 pages))
- Illustrations:
- Illustrations
- NLM Unique ID:
- 101770634 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/101770634